Investment Trusts

The Biotech Growth Trust PLC

BIOG:LSE

The Biotech Growth Trust PLC

Actions
  • Price (GBX)1,032.00
  • Today's Change-24.00 / -2.27%
  • Shares traded243.17k
  • 1 Year change+35.43%
  • Beta0.6315
Data delayed at least 15 minutes, as of Oct 08 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PriceThe Biotech Growth Trust PLC (Ordinary Share)+39.32%
NAVThe Biotech Growth Trust PLC (Ordinary Share)+34.35%
Morningstar's BenchmarkNASDAQ Biotechnology TR GBP--

Key statistics

On Tuesday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 1,032.00, -3.40% below its 52-week high of 1,068.36, set on Oct 07, 2024.
52-week range
Today
715.00Oct 26 20231,068.36Oct 07 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding31.86m
Market cap336.44m GBP
Total assets390.37m GBP
Total expense ratio1.18%
High1,058.00
Low1,032.00
Previous close1,056.00
Average volume110.28k
YTD Change+15.44%
Beta0.6315
Diluted NAV (est)1,093.99
Diluted NAV (last pub)1,102.79
Premium/Discount-5.67%
Net Gearing+6.05%
Data delayed at least 15 minutes, as of Oct 08 2024 16:35 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.